ArticleScientific reports2026
Biocompatibility of a novel directly printed orthodontic aligner at variable material thicknesses.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct printed aligners (DPAs) represent a revolution in aligner orthodontics, enabling in-office fabrication of customized removable orthodontic appliances and precise, region-specific thickness modulation within a single aligner. Accordingly, this study assessed whether the manufacturer's standard 20-minute UV post-cure is adequate to ensure biocompatibility of DPAs made from LuxCreo DCA resin (LuxCreo Inc., Chicago, IL, USA) as appliance thickness increases up to 6 mm. Specimen discs (Ø 10 mm) of varying thickness (0.5, 1, 2, 4, and 6 mm) were 3D printed and post-processed according to the LuxAlign (LuxCreo Inc., Chicago, IL, USA) closed end-to-end workflow. Thickness was verified by digital caliper and biocompatibility was assessed using the AlamarBlue assay on human gingival fibroblasts. Printed specimens closely matched nominal dimensions and cell viability always remained above 70%, the ISO 10993-5 threshold for non-cytotoxicity. No significant differences were observed between the standard 0.5 mm and thicker groups (1-6 mm), indicating that increased thickness did not further impair biocompatibility. These findings demonstrate that the standardized LuxAlign workflow, including a 20-minute UV-curing, produces dimensionally accurate, non-cytotoxic appliances from LuxCreo DCA resin up to 6 mm thickness, supporting safe clinical use without extending post-curing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.